bio
-
The Cyber-Biosecurity Nexus: Key Risks and Recommendations for the United States
Cyber-biosecurity threats are escalating as malicious actors target critical infrastructure, biotech firms, and research institutions. This briefer provides an overview of the trends and critical risks at the nexus of cybersecurity and biosecurity. It then offers high-level recommendations for addressing these risks.
-
CSR Biodefense Scorecard: Highlighting Progress on U.S. Policies & CSR Recommendations
As new strategies enter implementation stages, CSR is kicking off a writing series to publicly highlight the progress we are monitoring. This is the first in an ongoing series that will highlight the status of key Nolan Center recommendations we made in the past.
-
Key Biodefense Elements in the FY2024 President’s Budget Request
This briefer provides an overview of proposed biodefense spending in the U.S. government’s FY24 budget across all relevant federal agencies, including the Department of Defense, Health and Human Services, Homeland Security, and others. The Nolan Center’s analysis is designed to highlight notable changes in funding, potentially important new programs, and areas for improvement in vital…
-
Finland’s Accession to NATO: An Opportunity to Bolster Europe’s CBRN Defense
Finland’s long tradition of close security cooperation with NATO places the country in a unique position to lead the alliance in building toward the strategic concept of deterrence by denial across the full spectrum of CBRN threats.
-
Review: The UK Government’s Updated Biological Security Strategy
The UK has long had strong capabilities for addressing biological risks, yet more than ever its national strategy now recognizes the potential for biological threats to have catastrophic impacts and seeks to continue expanding on lessons from and capabilities developed during the COVID-19 pandemic.
-
Event Summary: Reauthorizing The Pandemic and All-Hazards Preparedness Act—Perspectives from the White House
On June 7, CSR hosted an event with former Executive Office of the President policymakers on the importance of reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA).
-
Event Summary: Advancing Biomanufacturing: U.S. Policies and Plans
On May 16th, The Council on Strategic Risks (CSR) hosted an event on the federal government’s strategy for driving innovation in biomanufacturing. The panel event featured expert perspectives from Dr. Georgia Lagoudas, Mr. Maynard Holliday, and Dr. Anup Singh. The panelists discussed how the federal interagency is positioning itself to capitalize on the transformative effects…
-
Event Summary: Reauthorizing the Pandemic and All-Hazards Preparedness Act—Perspective from Previous ASPR Leaders
On May 12th, CSR hosted an event with former leaders from HHS’s Administration for Strategic Preparedness and Response (ASPR) on reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA).
-
CSR Announces 2023-24 Class of its Fellowship for Ending Bioweapons Programs
The Council on Strategic Risks (CSR) is excited to announce the newest class of its Fellowship for Ending Bioweapons Programs. In a time of rising geopolitical tensions, rapid technological change, and an enduring pandemic, the potential devastation of biological risks is clearer now than ever. Whether natural, accidental, or deliberate, biological threats pose grave dangers…
-
Event: Advancing Biomanufacturing: U.S. Policies and Plans
On May 16 at 12:00pm ET, CSR will host a public event focused on this critical area of progress in U.S. biomanufacturing resilience.